Cargando…

Collecting Occupational Exposure Data Would Strengthen Idiopathic Pulmonary Fibrosis Registries

Detalles Bibliográficos
Autores principales:	Nett, Randall J., Wood, John M., Blackley, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049923/ https://www.ncbi.nlm.nih.gov/pubmed/31664850 http://dx.doi.org/10.1164/rccm.201908-1631LE

Ejemplares similares

Reply to Nett et al.: Collecting Occupational Exposure Data Would Strengthen Idiopathic Pulmonary Fibrosis Registries
por: Culver, Daniel A., et al.
Publicado: (2020)

Importance of Occupational Exposure Data: A National Idiopathic Pulmonary Fibrosis Registry Perspective
por: Teoh, Alan K. Y., et al.
Publicado: (2020)

Patient Registries in Idiopathic Pulmonary Fibrosis: Don't Forget Socioeconomic Status
por: Sesé, Lucile, et al.
Publicado: (2020)

Hypersensitivity Pneumonitis Mortality by Industry and Occupation
por: Hall, Noemi B., et al.
Publicado: (2019)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
por: Huang, Jin-Xian, et al.
Publicado: (2022)

Patient Registries in Idiopathic Pulmonary Fibrosis
por: Culver, Daniel A., et al.
Publicado: (2019)

Comparing Transbronchial Cryobiopsy and Surgical Biopsy in Idiopathic Pulmonary Fibrosis
por: Quadrelli, Silvia, et al.
Publicado: (2019)

Comments on COVID-19 Vaccination and Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kang, Tianlun, et al.
Publicado: (2022)

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Hematopoietic and Lung Platelet Biogenesis as a Prognostic Indicator in Idiopathic Pulmonary Fibrosis
por: Saito, Shigeki, et al.
Publicado: (2022)

Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kobayashi, Tetsu, et al.
Publicado: (2020)

Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: a matter of control
por: Bellaye, Pierre-Simon, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis Update: Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?
por: Moran-Mendoza, Onofre
Publicado: (2022)

Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
por: Suissa, Samy, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis and occupational risk factors
por: Ranzieri, Silvia, et al.
Publicado: (2019)

Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
por: Horita, Nobuyuki, et al.
Publicado: (2020)

Identification of autophagy-related genes in idiopathic pulmonary fibrosis using bioinformatics methods
por: Sun, Shulei, et al.
Publicado: (2022)

Reply: Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: a matter of control
por: Porter, Joanna C., et al.
Publicado: (2022)

Dental Personnel Treated for Idiopathic Pulmonary Fibrosis at a Tertiary Care Center — Virginia, 2000–2015
por: Nett, Randall J., et al.
Publicado: (2018)

Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations
por: Leavy, Olivia C., et al.
Publicado: (2021)

Genome-wide Enrichment of TERT Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino Ancestry
por: Zhang, David, et al.
Publicado: (2022)

No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients
por: Philippot, Quentin, et al.
Publicado: (2023)

CD71(−) Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease
por: Puxeddu, Ermanno, et al.
Publicado: (2019)

Construction of potential idiopathic pulmonary fibrosis related microRNA and messenger RNA regulatory network
por: Zhang, Yu-Feng, et al.
Publicado: (2021)

Reply to Moran-Mendoza: Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?
por: Raghu, Ganesh, et al.
Publicado: (2022)

The world is not enough – the value of increasing registry data in idiopathic pulmonary fibrosis
por: Moor, C. C., et al.
Publicado: (2020)

The Role of Occupational and Environmental Exposures in the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Narrative Literature Review
por: Trethewey, Samuel P., et al.
Publicado: (2018)

Identification of a Genetic Susceptibility Locus for Idiopathic Pulmonary Fibrosis in the 16p Subtelomere Using Whole-Genome Sequencing
por: Donoghue, Lauren J., et al.
Publicado: (2023)

From “traction bronchiectasis” to honeycombing in idiopathic pulmonary fibrosis: A spectrum of bronchiolar remodeling also in radiology?
por: Piciucchi, Sara, et al.
Publicado: (2016)

Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
por: Kondoh, Yasuhiro, et al.
Publicado: (2020)

Reply to Kobayashi et al.: Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kondoh, Yasuhiro, et al.
Publicado: (2020)

Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach
por: Faverio, Paola, et al.
Publicado: (2022)

Occupational Benzene Exposure and Lymphoma Risks
por: Sorahan, Tom
Publicado: (2011)

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
por: Snyder, Laurie D, et al.
Publicado: (2020)

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
por: Case, Amy Hajari, et al.
Publicado: (2020)

The ultra-connected generation would like to disconnect now
por: Cassan, Julie, et al.
Publicado: (2021)

Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
por: Raghu, Ganesh, et al.
Publicado: (2022)

A strong and independent Africa CDC would benefit the world
por: Evaborhene, Nelson Aghogho
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ib83jbi2rjn9a3t4jb0j4irbic